TAAs promote glioma invasion through the activation of several signaling pathways, such as nuclear factor kappa-B (NF-κB), interleukin (IL)-6/JAK/STAT, and sonic hedgehog (SHH) signaling (Figure 3). This evidence concerns the gene IL6 and central nervous system cancer.